Online ISSN: 2187-2988 Print ISSN: 0911-1794
特定非営利活動法人日本小児循環器学会 Japanese Society of Pediatric Cardiology and Cardiac Surgery
Pediatric Cardiology and Cardiac Surgery 38(4): 221-228 (2022)


成人先天性心疾患の心不全に対する薬の使い方のコツDrug Therapy in Adult Congenital Heart Disease with Heart Failure

九州大学循環器内科Department of Cardiovascular Medicine, Kyushu University Hospital ◇ Fukuoka, Japan

発行日:2022年12月1日Published: December 1, 2022


Currently, most patients with congenital heart disease (CHD) reach adulthood, and heart failure (HF) is one of the leading causes of death for adult patients with CHD. Therefore, an appropriate treatment strategy for HF is essential for improving their prognosis. Medical therapy for HF is as crucial as surgical or catheter-related therapy. Recently, novel agents for treating HF have emerged that have dramatically changed the strategy for HF therapy. Thus, updating knowledge of these therapeutic agents, both standard and novel, is vital. Hopefully, this article will be helpful in daily practice.

Key words: adult congenital heart disease; heart failure; heart failure with preserved ejection fraction; heart failure with reduced ejection fraction; medical therapy

This page was created on 2022-12-22T10:44:53.707+09:00
This page was last modified on 2023-02-21T18:17:39.000+09:00